.gif)
MOST NOTEWORTHY: Morgan Stanley, AstraZeneca and Lowe's were today's noteworthy downgrades:
- Goldman Sachs downgraded shares of Morgan Stanley (NYSE: MS) to Neutral from Buy as it believes declines in capital markets and commercial real estate, coupled with additional investment writedowns, will impact near-term earnings.
- AstraZeneca (NYSE: AZN) was lowered to Neutral from Overweight at HSBC. The firm expects further negative pressure on shares with the 30-month stay on an FDA approval of generic versions of low dose Seroquel set to expire in April 2008.
- Citigroup downgraded Lowe's Companies (NYSE: LOW) to Hold from Buy as it believes a Q4 miss and 2008 guidance will likely pressure shares in the near-term.
OTHER DOWNGRADES:
- Friedman Billings downgraded TiVo (NASDAQ: TIVO) to Underperform from Market Perform.
- Merriman downgraded Mentor Corp (NYSE: MNT) to Neutral from Buy.
- Goldman removed ProLogis (NYSE: PLD) from its Conviction Buy List.
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
Reader Comments (Page 1 of 1)
2-01-2008 @ 12:45PM
john murphy said...
despite upswing in stock stage stores still having trouble paying bills on new stores
2-01-2008 @ 12:39PM
john murphy said...
others having trouble are stage stores who cant pay for construction on new stores